Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT.

about

Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation.

P2860

Q49976405-DC7FE3A9-6E2A-45AE-86D4-07637CFA56DB

P2860

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT.

Item

http://www.wikidata.org/entity/Q48337179

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Low-dose 5-azacytidine as prev ...... MDS following allogeneic HCT.

@en

Low-dose 5-azacytidine as prev ...... MDS following allogeneic HCT.

@nl

type

Item

label

Low-dose 5-azacytidine as prev ...... MDS following allogeneic HCT.

@en

Low-dose 5-azacytidine as prev ...... MDS following allogeneic HCT.

@nl

prefLabel

Low-dose 5-azacytidine as prev ...... MDS following allogeneic HCT.

@en

Low-dose 5-azacytidine as prev ...... MDS following allogeneic HCT.

@nl

P1476

Low-dose 5-azacytidine as prev ...... MDS following allogeneic HCT.

@en

P2093

E Fares

http://www.w3.org/2001/XMLSchema#string

J El-Cheikh

http://www.w3.org/2001/XMLSchema#string

M A Kharfan-Dabaja

http://www.w3.org/2001/XMLSchema#string

M Charafeddine

http://www.w3.org/2001/XMLSchema#string

N Kreidieh

http://www.w3.org/2001/XMLSchema#string

R Mahfouz

http://www.w3.org/2001/XMLSchema#string

P2860

Post-remission therapy for acute myeloid leukemia

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.

Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT.

Risk-Adapted Approach to HLA-Matched Sibling Hematopoietic Cell Allografting: Impact of Adjusting Conditioning Intensity and Integrating Post-Transplant Therapeutic Interventions.

Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Gro

P2888

bmt.2017.31

P304

918-921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2017.31

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ali Bazarbachi

Radwan Massoud

P577

2017-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28368381

http://www.w3.org/2001/XMLSchema#string

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT.

about

P2860

P2860

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698